MRK Merck Common (New)150.51-2.04 (-1.3%)
MRK Merck Common (New)153.20+4.21 (+2.8%)
MRK Merck Common (New)149.74-2.46 (-1.6%)
Outlook is neutral, with stock confined to a band of ±3%
Strategy has +34% ROI potential and 19% overvalued
MRK 150.66+15.49 (+11.5%)Merck Common (New)
MRK 150.66+15.49 (+11.5%)Merck Common (New)